Redx Pharma (REDX)

Company name:Redx Pharma Plc
EPIC:REDXTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BSNB6S51
Market Segment:ASQ1Share Type:DE
WWW Address: 1P
 Price Price Change [%] Bid Offer Open High Low Volume
 56.50 0.0 [0.00] 53.00 60.00 56.50 56.50 56.50 38
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 155.25 274.78 -0.02 -5.40 - - - 92.50 - 25.00

Redx Pharma Key Figures

(at previous day's close)
Market Cap.155.25m
Shares In Issue274.78m
Prev. Close56.50
PE Ratio- 
Dividend Yield-%
EPS - basic-5.40p
Dividend PS-p
Dividend Cover- 
Cash Flow PS0.14p
Return On Equity (ROE)-342.87%
Operating Margin-161.27%
PEG Factor- 
EPS Growth Rate-58.82%
Dividends PS Growth Rate-%
Net Debt3.39m
Gross Gearing92.00%
Quick Assets29.47m
Net Working Capital18.53m
Intangibles / Fixed Assets96.70%
Turnover PS2.07p
Pre-Tax Profit PS-3.34p
Retained Profit PS-3.35p
Cash PS10.01p
Net Cash PS6.03p
Net Tangible Asset Value PS *-0.47p
Net Asset Value PS0.98p
Spread7.00 (11.67%) 

Redx Pharma Balance Sheet


Share Price Performance

Sample Period HighLow
1 week57.5056.50
4 weeks61.5053.50
12 weeks68.2053.50
1 year92.5025.00

Share Price Chart (5 years)

Redx Pharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week57.50-1.00-1.7456.500.0356.62
4 weeks61.50-5.00-8.1353.500.1256.62
12 weeks66.50-10.00-15.0453.500.0557.82
26 weeks59.00-2.50-4.2453.500.0360.60
1 year25.0031.50126.0025.000.0758.48
3 years9.2547.25510.814.850.1420.05
5 years27.7528.75103.603.500.1723.24

Redx Pharma Key Management Ratios

Redx Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio1,079.00 
PE Ratio- 
Tobin's Q Ratio 7.77 
Tobin's Q Ratio (excl. intangibles)8.74 
Dividend Yield-%
Market-to-Book Ratio57.78 
Price-to-Pre-Tax Profit PS-16.93 
Price-to-Retained Profit PS-16.85 
Price-to-Cash Flow PS393.04 
Price-to-Sales PS27.31 
Price-to-Net Tangible Asset Value PS-119.70 
Price-to-Cash PS5.64 
Net Working Capital PS6.74 
Price Pct to Working Capital PS8.38%
Earnings Yield-%
Average PE23.13 
Years in average1 
PE to PE average-%

Redx Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio88.14%
Debt-to-Equity Ratio7.43 
Debt-to-Equity Ratio (excl. Intgbl)-15.39 
Debt-to-Equity Market Value0.13 
Net Gearing10.09%
Net Gearing (excl. Intangibles)11.44%
Gross Gearing92.00%
Gross Gearing (excl. Intangibles)104.38%
Gearing Under 1 Year32.55%
Gearing Under 1 Year (excl. Intgbl)36.93%
(Liquidity Ratios)
Net Working Capital to Total Assets55.18%
Current Ratio2.70 
Quick Ratio (Acid Test)2.70 
Liquidity Ratio2.52 
Cash & Equiv/Current Assets93.37%
(Solvency Ratios)
Enterprise Value147.71m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.20 
Total Debt/Sales5.44 
Total Debt/Pre-Tax Profit-3.37 
Total Debt30.90m
Total Debt/Net Current Assets1.67%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-8.29%
5 yr Compound Earnings Growth-22.88%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs3 
Beta (60-Mnth)Beta (36-Mnth)

Redx Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-40.47%
Return On Assets (ROA)-46.13%
Net Profit Margin-162.06%
Assets Turnover0.28 
Return On Equity (ROE)-342.87%
Return On Investment (ROI)-76.31%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-162.06%
(Asset Utilisation Multiples)
Shareholders Equity Turnover2.72 
Fixed Assets Turnover2.43 
Current Assets Turnover0.32 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales3.51 
Debt Collection Period130.27Days

Redx Pharma Dividends

Sorry No Data Available

Redx Pharma Fundamentals

 30 Sep 2017 (GBP)30 Sep 2018 (GBP)30 Sep 2019 (GBP)30 Sep 2020 (GBP)
pre tax profit1.655.40%-10.15--6.34-202.33%-9.17-161.27%m
attributable profit1.535.01%-8.85--4.32-137.91%-9.21-162.06%m
retained profit1.535.01%-8.85--4.32-137.91%-9.21-162.06%m
eps - basic (p)1.40 -7.00 -3.40 -5.40 
eps - diluted (p)1.40 -7.00 -3.40 -5.40 
dividends per share- - - - 

Redx Pharma Balance Sheet

 30 Sep 2017 (GBP)30 Sep 2018 (GBP)30 Sep 2019 (GBP)30 Sep 2020 (GBP)
 30 Sep 2017 (GBP)30 Sep 2018 (GBP)30 Sep 2019 (GBP)30 Sep 2020 (GBP)
fixed assets fixed assets0.220.80%0.191.85%0.132.11%0.140.40%m
intangibles intangibles0.431.55%0.424.10%0.426.56%3.9811.86%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors3.2311.67%3.2331.34%2.1033.08%1.965.82%m
cash & securities cash & securities23.8185.98%6.4762.71%3.7058.26%27.5181.91%m
creditors - short creditors - short13.3648.26%3.9538.28%4.8776.55%10.9332.55%m
creditors - long creditors - long--%0.615.86%--%19.9759.45%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves14.3351.74%5.7655.86%1.4923.45%2.698.00%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Redx Pharma Cash Flow Statement

30 Sep 2017 (GBP)30 Sep 2018 (GBP)30 Sep 2019 (GBP)30 Sep 2020 (GBP)
Operating CF14.10-17.18-4.670.40m
Pre-Financing CF14.07-17.29-4.640.34m
Retained CF18.05-17.34-2.7723.81m

Redx Pharma Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
Redx Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210725 23:24:47